Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110674422 | 11067442 | 2 | F | 2009 | 20160721 | 20150427 | 20160817 | PER | US-ASTRAZENECA-2010BM01866 | ASTRAZENECA | 73.00 | YR | M | Y | 104.30000 | KG | 20160817 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110674422 | 11067442 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 5 | UG | INJECTION | BID | |||||||
| 110674422 | 11067442 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | A677501A | 21773 | 10 | UG | INJECTION | BID | ||||||
| 110674422 | 11067442 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | A683141A | 21773 | 10 | UG | INJECTION | BID | ||||||
| 110674422 | 11067442 | 4 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | A697780A | 21773 | 10 | UG | INJECTION | BID | ||||||
| 110674422 | 11067442 | 5 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | A642386A | 21773 | 10 | UG | INJECTION | BID | ||||||
| 110674422 | 11067442 | 6 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | C199747A | 21773 | 10 | UG | INJECTION | BID | ||||||
| 110674422 | 11067442 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | QD | 0 | |||||||||||
| 110674422 | 11067442 | 8 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110674422 | 11067442 | 1 | Type 2 diabetes mellitus |
| 110674422 | 11067442 | 2 | Type 2 diabetes mellitus |
| 110674422 | 11067442 | 3 | Type 2 diabetes mellitus |
| 110674422 | 11067442 | 4 | Type 2 diabetes mellitus |
| 110674422 | 11067442 | 5 | Type 2 diabetes mellitus |
| 110674422 | 11067442 | 6 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110674422 | 11067442 | Blood glucose increased | |
| 110674422 | 11067442 | Decreased appetite | |
| 110674422 | 11067442 | Incorrect dose administered by device | |
| 110674422 | 11067442 | Intentional product misuse | |
| 110674422 | 11067442 | Product quality issue | |
| 110674422 | 11067442 | Seasonal allergy | |
| 110674422 | 11067442 | Therapy cessation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110674422 | 11067442 | 1 | 200709 | 200710 | 0 | |
| 110674422 | 11067442 | 2 | 2007 | 0 | ||
| 110674422 | 11067442 | 4 | 200710 | 0 | ||
| 110674422 | 11067442 | 5 | 200912 | 0 | ||
| 110674422 | 11067442 | 6 | 2008 | 0 |